Embed Size (px)
Citation preview
Healthcare – Singapore
Sector Report
Healthcare
Singapore
Produced by:Ms Valsa Panicker, Senior Trade & Investment Attache, British High Commission, Singapore
Last revised: July 2009
Whereas every effort has been made to ensure that the information given herein is accurate, UK Trade & Investment or its sponsoring Departments, the Department for Business, Innovation & Skills and Foreign & Commonwealth Office, accept no responsibility for any errors, omissions or misleading statements in that information and no warranty is given or responsibility is accepted as to the standing of any firm, company or individual mentioned.
www.uktradeinvest.gov.uk
Healthcare – Singapore
Table of Contents
OVERVIEW 3
CHARACTERISTICS OF THE MARKET 4
OPPORTUNITIES 6
KEY METHODS OF DOING BUSINESS 12
PUBLICATIONS 13
EVENTS 14
CONTACT LISTS 17
www.uktradeinvest.gov.uk Page 2 of 20
Healthcare – Singapore
OVERVIEW
Since Singapore’s independence in 1965, its concerted and farsighted efforts in economic development have resulted in almost uninterrupted growth of nearly 8% per annum for over three decades. Despite its small size (707km²), population base (4.7 million), and its lack of natural resources, Singapore’s business friendly environment, significant foreign investment, and constant efforts to maintain a competitive edge, have resulted in consistent economic growth over the years, and a per capita GDP of S$52,994 (2007) [approximately £24,400]. The economy grew by 7.9% in 2006, 7.5% in 2007 and but grew by 1.2% in 2008. Growth in 2009 is predicted to be between –5% to –2% due to sharp, protracted recession envisaged due to the global economic downturn. Singapore’s strategic location has historically made it a major trading hub, and annual trade is valued at 3 times its GDP.
Singapore is the UK’s ninth largest export market outside of Europe. In 2006, UK product exports to Singapore exceeded £2.3 billion and imports from Singapore totalled £3.8 billion. The UK is the largest overseas investor in Singapore. The cumulative stock of UK foreign direct investment in Singapore stood at £19.5 billion in 2006.
Biomedical Sciences, comprising pharmaceuticals, biotechnology and medical technology, has grown to be the third largest manufacturing cluster after electronics and chemicals, following investment of nearly $3 billion since 2000. It now accounts for over 20% of the sector’s value add, contributing 6% to the GDP. The BMS industry has grown rapidly at a compounded annual growth of 23% since 2000, and reached S$24 billion in manufacturing output in 2007, well on track to reach the earlier target of $25 billion, and employment of 15,000 by 2015. Singapore’s aim is to develop the sector to reach world class standards, and to encompass the entire value chain, from basic research to clinical trials, product/process development, full-scale manufacturing and health care delivery.
Singapore’s medical standards are among the highest in Asia and it is widely acknowledged as a regional centre for medical excellence. It currently holds one percent of the total healthcare market in Asia. The Healthcare Services Workgroup, under the Economic Review Committee, plan to raise this to 3% and develop Singapore into the leading healthcare services centre in Asia, by promoting medical tourism under the SingaporeMedicine initiative. In 2005, 374,000 foreign patients sought medical treatment in Singapore, of which 27,766 received hospital care. 80% of foreign in-patients seek treatment in private hospitals. Both the public and private sectors have announced an increase in foreign patients, who make up 30-40% of the patient base in the private sector. In view of the rising competition from the region, healthcare operators are aware that they need to constantly innovate on their service delivery, invest in the latest technology, upgrade skills, and undertake regular training.
www.uktradeinvest.gov.uk Page 3 of 20
Healthcare – Singapore
The Government has announced the target of attracting 1 million patients by 2012, generating $3 billion, by developing Singapore as a hub for clinical medical specialities as well as for ‘economic medical’ services.
Singaporeans enjoy a high standard of health. There are 7,384 registered doctors with a doctor-population ratio at 1:620, one of the highest in the region (2007). 3991 are in the public sector and 3004 in the private sector. 35% of the doctors are specialists with advanced training. 2500 are in General Practice. There are 1,354 registered dentists with 287 in the public sector and 881 in the private sector, with a dentist-population ratio of 1:3,390. The total number of registered nurses/midwives is 22,332, with 12,294 and 6,112 in the public and private sectors respectively. The nurse-population stands at 1:210.
The average life expectancy is 78.9 years, with 77.4 years for men, and 81.3 years for women. Infant mortality rate is 2.2 per 1000 births, while maternal mortality rate is 1.2 per 10,000 births. The leading causes of mortality are cancer, coronary heart disease, stroke, pneumonia, diabetes, hypertension and injuries. Singapore ranks first globally for the lowest infant mortality rate and the fourth for life expectancy. A recent WHO report ranked the Singapore healthcare system to be the sixth most effective among the 191 countries surveyed.
Frost & Sullivan valued the Asian healthcare market at US$240 billion in 2008, with pharmaceuticals accounting for 66% of the market and medical devices at 21%.
CHARACTERISTICS OF MARKET
In Singapore, healthcare is offered by both the public and private sectors. The former accounts for 80% tertiary care and 20% primary care, with the private sector accounting for the rest. There are a total of 29 hospitals and speciality centres to provide both general secondary and specialist services, with 1,900 primary care clinics and 18 government polyclinics.
The public sector is organised into two clusters, National Healthcare Group (NHG) and Singapore Health Services (SingHealth), which cater to the western and eastern parts of the country respectively. They aim to provide seamless and patient-centred care through the 18 polyclinics, 7 hospitals and 6 speciality centres. A third cluster, Alexandra Health was set up in 2008, which will include the new Khoo Teck Puat Hospital. The government encourages personal responsibility through a system of co-payment for healthcare services.
The private sector comprises around 1,900 clinics and 16 hospitals, and includes Parkway Group Healthcare which offers primary, tertiary, dental, diagnostic and contract research services in Singapore and the region. Several private operators offer their clinical and management expertise overseas, mainly through joint ventures.
www.uktradeinvest.gov.uk Page 4 of 20
Healthcare – Singapore
Total health spend is estimated at around 3.7% of GDP, low when compared with OECD countries. This figure is likely to increase significantly in the next twenty years because of Singapore’s ageing population profile. The ultimate challenge for the government lies in providing good quality medical care to Singaporeans, while ensuring increases in health care costs are affordable to the nation and maintaining Singapore’s edge as the leading provider of high technology medicine in the region.
The Ministry of Health’s five priority programmes are: to improve the health of the elderly; strengthening the management of the main killer diseases; enhancing child health services; improving mental health care; and health promotion and disease prevention. Major challenges include rising healthcare costs, increasing demand for improved services, an ageing population and manpower shortages from doctors to nurses and ancillary personnel.
In February 08, MOH announced an investment of $1.9 billion over the following 5 years to upgrade public hospitals and build a new hospital ($900 million), and raise the quality of healthcare professionals ($1 billion).
Under the 2009 Budget, $4 billion was committed over 5 years to expand the healthcare infrastructure to include:
Redevelopment of older hospitals, medical centres and a new hospital in the west, and current projects like the Khoo Teck Puat Hospital in the north; the new National Heart Centre and a Pathology Lab at the Singapore General Hospital.
Building new community hospitals and boosting capabilities in treating chronic diseases (e.g. stroke, heart and kidney failure) and other age-related conditions (e.g. dementia);
Training healthcare professionals from doctors and nurses to physiotherapists and pharmacists ($500 million)
Enhancing capabilities for long-term care (including rehabilitation, home care and palliative services after patients have been discharged from hospitals); and
Developing an electronic health records system that will be accessible by authorised medical practitioners at hospitals and polyclinics, and eventually extending to the community care sector.
Research and public health initiatives.
The significant investment in the biomedical sciences sector has led to major international companies setting up base in Singapore for manufacturing and R&D, besides their regional sales and marketing operations. GSK for instance, is a major investor in Singapore and continues to expand with a new R&D centre and a new S$600 million vaccine plant. Other significant
www.uktradeinvest.gov.uk Page 5 of 20
Healthcare – Singapore
investors include Merck, Pfizer, Schering Plough, Novartis, Wyeth, Lonza, Genentech and Sanofi-Aventis. International medical devices companies include Baxter, Becton Dickinson, Ciba Vision, Fisher Scientific, Biosensors, and Hoya Healthcare among others. New investments in plants and R&D centres continue to flow in, and renowned scientists advise and steer Singapore’s biomedical strategy and helm the major research institutes. The Johns Hopkins International Medical Centre, the US Hospital’s first venture overseas, operates as a private hospital within the Tan Tock Seng Hospital, offering local and international patients the latest cancer care and research under the management and standards of Johns Hopkins.
There is also indigenous manufacture of generic pharmaceuticals and medical devices, and a strong supporting industry. The increase in R&D funds to the 3 key sectors of biomedical sciences, water and environment, and creative and media, of $13 billion over 5 years, is likely to spur commercialisation of new biomedical products and processes, and further establish Singapore as a major base for the full spectrum of activities in the sector.
OPPORTUNITIES
Singapore is committed to remaining at the forefront of health care provision as the regional centre of medical excellence. Both the public and private sectors are well funded and are continually seeking to upgrade their services and facilities. The Government has reaffirmed Singapore’s interest in staying ahead in high tech medicine, and has called on the private sector to keep abreast of latest developments and to invest in the emerging technology, to maintain Singapore’s edge in providing quality medical care.
New technology: Doctors in Singapore have developed capabilities in complex procedures such as organ transplant, assisted reproduction, limb reattachment, joint replacement, separation of conjoined twins, and the world’s first umbilical cord transplant. New methods of medical treatment are constantly being tested and introduced, and the universities work together with the hospitals to research and develop new medical devices, implants, etc. Translational medicine from the bench to the bedside is the focus of the second phase of the biomedical sciences initiative. Companies with innovative products could seek to work with hospitals, to research and test the products, which would be a good reference for their eventual marketing in Asia. One example is UK-based pSiMedica working with Singapore General Hospital on their novel cancer fighting technology.
Information Technology: There is increasing use of IT in training, administration and service provision. Both large and small hospitals are exploring full computerisation of their inventory systems, patient data records and link up of all activities from admission to discharge. Electronic Medical Record Exchange (EMRX), was initiated by the Ministry of Health to enable both public sector clusters to fully exchange and share patient information across primary and tertiary care institutions.
www.uktradeinvest.gov.uk Page 6 of 20
Healthcare – Singapore
A national electronic health record system will be implemented by 2010, when patients can move seamlessly from their polyclinics or GPs to public, private or community hospitals, as all the patient’s data will be in a consolidated file, encompassing notes on the medical condition, drug allergies, treatment and test results.
Singapore is also keenly exploring RFID technology, and the Agency for Science, Technology & Research (A*STAR) partnered 4 local companies in Sept 07, to develop it for the healthcare and other sectors. Singapore is also enhancing its telemedicine links, and is set to be a tele-radiology hub for the electronic transfer to medical radiographic images for off shore consultation, by going filmless. This will enable quick transmission for overseas consultations, as well as for other countries to send films for consultation and interpretation in Singapore.
New Medical Universities
A new graduate medical school in collaboration with Duke University, USA, will be built at the Outram Campus, a joint venture with the National University of Singapore. The Duke-NUS Medical School will be ready by 2009. In the meantime, it has started at an interim campus in August 2007 with an annual intake of 50 students on a 5 year course, which will be very research led, to produce clinician-scientists. The Outram Campus Master Plan also includes plans for schools for nurses, and other professionals such as physiotherapists.
A third medical school is planned to be set up at Nanyang Technological University (NTU). Imperial College London that draws on its strengths in engineering and science is cited as a model for the NTU medical school and a collaboration is now explored.
Two New General Hospitals
1. The Khoo Teck Puat Hospital is a $500 million, 550-bedded hospital to be completed by 2010. Located in a 3 ha plot in Yishun Central, in the north of Singapore, it will have general and specialist services, with a strong focus on day surgery and will be located next to Yishun Polyclinic for primary care. A community hospital, nursing home and rehabilitation centre are planned around for full step down care. The hospital site would also have room for further expansion. It will increase the public sector beds to 6,500.
2. A second new hospital, the Jurong General Hospital, will be built in the west, to be completed by 2014. A community hospital and a nursing home are also planned alongside.
Other projects
www.uktradeinvest.gov.uk Page 7 of 20
Healthcare – Singapore
New $300-500 million, 350-bedded private hospital to be developed by Parkway Group Healthcare, at a total cost of S$1.5 billion for the 1.7 ha site at Novena, to be completed by 2011. The Communicable Disease Centre in the area is being rebuilt, as well as a private medical centre, and a hotel, to support medical tourists.
Farrer Park Mediplex, comprising 200 specialist medical suites, a functionally interlaced 230 bedded hospital and the 260-room four star hotel located above the Farrer Park MRT station. It will comprise a 6 storey podium, rising to 19 storeys via 2 connected high rise wings. Total estimated cost for the project is $400 million. To be operational by 2011.
Redevelopment of the National Heart Centre by 2011. It will have a floor area of 30,000 sq m compared to the current NHC’s 5,200 sq m. Work started in early 2008. NHC will offer outpatient care with in patient services at SGH.
Extension of the National University Hospital.
Two new speciality centres at NUH for cancer and heart disease to complement the national cancer and heart centres in the SingHealth cluster.
Two new community hospitals linked to the upcoming Khoo Teck Puat Hospital and the planned Jurong General Hospital by 2016.
New pathology laboratory at Singapore General Hospital at $200 million by 2010.
A new S$9 million cell therapy facility was opened in August 09 by the Health Sciences Authority to conduct trials and develop cell based therapies.
Institute of Investigational Medicine housing clinician scientists, to transform research results to new drugs and treatment methods by 2010.
A new complex to integrate tracking and treating of infectious diseases, research and training of health care workers at the Communicable Disease Centre (CDC) premises.
$256 million investment in the Cancer Research Centre of Excellence over 7 years, to accelerate cancer research and develop cures in cancers prevalent among Asians.
New $42 million 24-hour private cancer centre to be built at the former Adam Road hospital, by Pacific Healthcare. To be ready by early 2011, it will be headed by US cancer specialist Dr Steven Tucker.
Expansion of the second dental centre within the National University Health System.
www.uktradeinvest.gov.uk Page 8 of 20
Healthcare – Singapore
MOH to support Voluntary Welfare Organisations (VWOs) to expand nursing home capacity from 9,200 to 14,000 beds over the next decade (May 09). 2,000 more nursing home beds are planned in the next five years, and five new nursing homes in the next two years. These will include:- a 300-bed nursing home for patients with psychiatric problems by
2012 - two 250-bed nursing homes for patients suffering from dementia
(currently there are 20,000 dementia patients which will rise to 45,000 by 2020)
- Release of plots for two private nursing homes- New and larger facilities for two nursing homes run by Voluntary
Welfare Organisations (VWOs).
Manpower expansion and training in healthcare.
The MOH plans to set up a committee to study new specialty centres Singapore will need in the future, taking into account the emerging disease trends, projected demand and clinical capabilities, including geriatric medicine and infectious diseases. Specialist centres, bigger labs, new research and teaching facilities and centres are in the pipeline.
Care of the Elderly: Singapore has one of the most rapidly ageing populations in Asia and will have the world’s 4th oldest population by 2050. The Government’s policy is to encourage family and home based care over institutionalised care, with access to community based services, for the estimated 800,000 elderly Singaporeans by the year 2030. The Government strategy to reduce the burden on acute care hospitals is to build community hospitals and nursing homes around three regional hospitals to provide high quality, low cost ‘step down facilities’ for non-acute medical care and rehabilitation services.
The Government is also keen to increase the current share of the private sector nursing homes from 25% to 40% of the total by 2010. It has earmarked 15 sites for private nursing homes, each targeted for homes with 200 beds.
Apart from comprehensive training of health care workers, additional services to provide a seamless, integrated long term care infrastructure for the elderly include home aids, transport services, community care, and modifying homes to suit the needs of the frail and disabled elderly.
The Housing and Development Board (HDB), the agency responsible for the construction of government subsidised housing, introduced studio apartments for the elderly in 1998, equipped with several elderly friendly features. There are a total of 936 studio flats in 6 new towns that incorporate elderly friendly features, such as non-slip floors and emergency cords in bathrooms. HDB is also exploring the idea of studio flats integrated into regular HDB blocks and homes with removable walls and partitions to allow ageing in place, and to build more such flats. Under the Project to Improve the Living Conditions of the Elderly, HDB will continue to upgrade several
www.uktradeinvest.gov.uk Page 9 of 20
Healthcare – Singapore
blocks with elderly friendly equipment and devices. Consequently, there are opportunities for products ranging from IT enabled assistive technology, mobility and self-help aids, medical kits and alarms to a wide array of elderly-friendly products.
Mental Health
The Government had allocated $88 million in 2007 to build Singapore into a mentally resilient society, of which $40 million was to be invested over 5 years to build community based capabilities and networks. MOH set up four multi-disciplinary programmes to detect and treat mental health problems early, and reintegrate and rehabilitate mental health patients into the community.
A further $35 million was set aside in 2009 to strengthen capabilities and for customised programmes for different age groups – children, adults and the elderly, as recommended by the National Mental Health Working Group, headed by Permanent Secretary for Health, Ms Yong Ying-I.
Regulations
On 1 April 2001, Health Sciences Authority (HSA), a statutory board under MOH was set up as a one stop regulatory agency for all therapeutic products, which comprises 8 professional centres:
Centre for Drug Administration (CDA) Centre for Medical Device Regulation (CMDR) Centre for Radiation Protection (CRP) Centre for Transfusion Medicine (CTM) Centre for Forensic Science (CFS) Centre for Forensic Medicine (CFM) Centre for Analytical Science (CAS)
However, a number of other healthcare professions are yet to come under statutory regulation. These include physiotherapy, occupational therapy, speech therapy, chiropody, osteopathy, etc.
Current regulations covering medicines and health related products include: the Medicines Act, the Poisons Act, the Sale of Drugs Act, and the Medicines (Advertisement and Sale) Act. The HSA has tabled a bill for a Health Products Act that will incorporate all 4 acts for ease of reference and compliance. The new regulation will be wide ranging and will include ‘any substance, preparation or device used for therapeutic, preventive, palliative, diagnostic or cosmetic purpose’ and flexible to cater to new products such as drug eluting stents, and biologics.
HSA announced a phased implementation of the registration of medical devices in November 2007:
www.uktradeinvest.gov.uk Page 10 of 20
Healthcare – Singapore
Phase One began in November 07, under which dealers will have to report adverse events and recall products when instructed by HSA.
Phase Two, spanned 1 April 2008 to 1 October 2009 comprising:
Licensing of dealers of medical devices Product registration
- of medium and high risk medical devices- of low risk medical devices
The amount of technical information required for registration will increase with the risk profile of the equipment. The deadline for registration of medium and high-risk products like heart valves and angioplasty catheters is October 2009. For low-risk products, it will be a year later. Phase Three will take place between 1 October 2009 and 2010. This comprises prohibition against unlicensed parties dealing in medical products, and prohibition against the supply of unregistered high risk, medium risk and low risk medical devices.
According to HSA, around 4,500 devices and more than 200 firms are already covered under a voluntary product registration scheme (VPRS). The details of products and firms listed under this scheme will be transferred to the new programme. HSA estimates that there are about 10,000 medical devices in the Singapore market.
In general, there are wide ranging opportunities for UK medical suppliers, from replacement items to high tech medicine. Recent trends include increasing use of minimally invasive surgical techniques; the use of customised prepacked sterilised surgical kits; and other efficient and cost saving products and procedures, as day surgery accounts for nearly half the hospital procedures. With the market well supplied and highly competitive, British products must be innovative and price competitive to gain a substantial share of the market.
KEY METHODS OF DOING BUSINESS
In the public sector, the Group Purchasing Office located at Singapore General Hospital, (www.gpo.nhg.singhealth.com.sg), arranges the bulk purchases of commonly used products for both NHG and SingHealth, in the following categories.
Generic and selected proprietary drugs Surgical and medical supplies Other materials and supplies
The website highlights changes in the procurement system, as of 1 March 05, including changes to the open tender process, and two new procurement tools ‘Request for Proposal (RFP)’ and ‘Reverse Auctions’, designed to offer greater flexibility over the traditional purchasing methods.
www.uktradeinvest.gov.uk Page 11 of 20
Healthcare – Singapore
The NHG also has its own GPO (www.nhg.gov.sg), for cluster specific purchases. Individual hospitals and specialist centres also have their own tender websites.
While a UK company can supply directly to the public sector, it is advisable to work through a local representative, who can make regular contact with the customers, provide product presentations, attend the required RFP briefings, and are aware of new opportunities, competitors, etc. The institutions also prefer to work with local agents/distributors, for ease of contact, and most importantly for the critical back up support. It is advisable to appoint one exclusive distributor in Singapore due to the size of the market. The local representative is also likely to be aware of regional opportunities, and most Singapore companies traditionally have well established networks in regional markets.
The UK Trade & Investment Section (UKTI) at the British High Commission (BHC) can assist in identifying the right agent or partner by producing bespoke tailored and verified market information. These and other chargeable services, which can be commissioned in the UK through the UKTI offices set up across the UK, are delivered on-line (www.uktradeinvest.gov.uk) by UKTI offices worldwide. Besides the High Commission, other Singapore-based organisations offering assistance include Singapore's Economic Development Board (EDB) and International Enterprise Singapore (IE Singapore). Both EDB and IE Singapore have offices in the UK.
In common with much of Asia, Singapore is a market where the personal touch is all-important and face to face contact is vital. While it is possible to sell "at arm's length", regular visits are essential. Once contact with a likely partner has been established, firms should consider an early visit to Singapore, possibly as a member of a UK Trade & Investment supported trade mission. An alternative option is participation in UK Trade & Investment supported trade fairs and trade missions. Participation in these events will provide an excellent opportunity to take a close look at the market for your product/service, and to identify the right lead or contact, leading to your gaining a foothold in the market. The next healthcare mission to Singapore is from 10 – 11 September 2009, which will be followed by visits to Malaysia and Thailand.
Once the product and the brand are well established, many companies consider a more permanent presence by opening up their own offices here. There is a wide choice of business premises available, from serviced offices, to business parks. There are more than 5000 MNCs in Singapore, a majority of which use Singapore as their South East Asian or Asia Pacific HQ. The Economic Development Board (www.edb.gov.sg), offers a range of incentives for new start ups in Singapore.
For more information, please contact:
www.uktradeinvest.gov.uk Page 12 of 20
Healthcare – Singapore
Ms Valsa PanickerSenior Trade & Investment AttacheUK Trade & InvestmentBritish High Commission100 Tanglin RoadSingapore 247919Tel: 65 64244 311Fax: 65 64244 356E-mail: [email protected]: www.britain.org.sg
PUBLICATIONS
The MOH website (www.moh.gov.sg) gives useful information on a variety of subjects, under the section on ‘Statistics, Publications and Resources’. These include Information Papers, Reports/Surveys, Newsletters/Bulletins, etc.
Another useful website is www.biomed-singapore.com, which gives a good overview of the development of the biomedical sciences sector. It has links to the various government organisations involved in the sector.
Each hospital also has its own newsletter, on their events, and recent developments.
The Singapore Pharmaceuticals & Healthcare Report 2008-12
Contact: Jamie DaviesHead of Pharmaceuticals & Healthcare Market IntelligenceBusiness Monitor InternationalMermaid House2 Puddle DockLondon EC4V 3DSTel: 44 20 7248 0467Fax: 44 20 7248 0468E-mail: [email protected]: www.businessmonitor.com/pharma/singapore.html
EVENTS
HOSPIMEDICA ASIA 2008 (NOW MEDICAL FAIR ASIA – next event in 2010)
7th International Exhibition on Hospital, Diagnostic, Pharmaceutical, Medical & Rehabilitative Equipment & Supplies
www.uktradeinvest.gov.uk Page 13 of 20
Healthcare – Singapore
Date: 17 – 19 September 2008
Venue: Suntec Singapore
Website: www.hospimedica-asia.com
Organiser: Messe Duesseldorf Asia Pte Ltd3 HarbourFront Place#09-02 HarbourFront Tower TwoSingapore 099254
Tel: 65 6332 9620Fax: 65 6332 9655E-mail: [email protected]
A UK pavilion of 8 companies was organised by the Association of British Healthcare Industries, and supported by UK Trade & Investment.
This show alternates between Singapore and Bangkok (Medical Fair Asia: 16 – 18 September 2009). Details of the next show in Singapore awaited.
INTERPHEX EXHIBITION & INTERNATIONAL SOCIETY FOR PHARMACEUTICAL ENGINEERING (ISPE) SINGAPORE CONFERENCE
Date: 1 – 2 June 2009
Venue: SUNTEC Singapore
Organiser: Reed Exhibitions Pte Ltd#07-01, The Signature51 Changi Business Park Central 2Singapore 486066Tel: 65 6780 4641 Fax: 65 6588 3832www.reedexpo.comProject Manager: Ms Rhonda NgTel: 65 6780 4624E-mail: [email protected]
Ms Dayna ChuaTel: 65 6780 4697E-mail: [email protected]
The exhibition, which offers a one-stop platform to meet with pharmaceutical manufacturing professionals, and to showcase products, equipment and services to the pharmaceutical industry, attracted over 870 visitors from 31 countries 108 exhibitors from 15 countries in 2008.
www.uktradeinvest.gov.uk Page 14 of 20
Healthcare – Singapore
FDI WORLD DENTAL CONGRESS
Date: 2 – 5 September 2009
Venue: Singapore International Convention & Exhibition Centre
Organiser: [email protected]
AESTHETICS ASIA EXHIBITION AND CONGRESS 2009
Date: 4 - 6 September 2009
Venue: Raffles Convention Centre, Fairmont Hotel, Singapore
Organiser: Magdalene Leong, Sales ManagerIIR Life Sciences Division205 Henderson Road #03-01 Henderson Industrial Park,Singapore 159549Tel: +65 6319 2668 DID: +65 6517 3018 Fax: +65 6319 2669Email: [email protected]
Website: www.aestheticsasia.com
Conferences on Biomedical & Pharmaceutical Industries
Organiser: IBC Asia (S) Pte LtdNo 1 Grange Road#08-02 Singapore 239693Tel: 65 6732 1970 Fax: 65 6733 5087E-mail: [email protected]: www.ibclifesciences.com
IBC Asia organise a series of conferences on the biomedical sciences, with small exhibitions held alongside.
3rd Annual BioPharm Asia 2008 8 – 11 Sept 085th Annual Clinical Trials Summit 2008 29 – 30 Oct 082nd Annual Healthcare Operations Management 29 – 31 Oct 084th Annual Diagnostics & Medical Devices Asia 24 - 25 March 09World Vaccine Congress Asia 9 – 10 June 09Healthcare Travel Exhibition & Congress 28-30 June 2009
www.uktradeinvest.gov.uk Page 15 of 20
Healthcare – Singapore
CONTACT LISTS
Ministry of Health College of Medicine Building16 College RoadSingapore 169854 Tel: 65-6325 9220 Fax: 65-6224 1677E-mail: [email protected]
Ministry of Community Development, Youth & Sports (MCYS)MCYS Building512 Thomson RoadSingapore 298136
Tel: 65–6258 9595 Fax: 65–6353 6695E-mail: [email protected]
Singapore Health Services Pte Ltd (Eastern Cluster)31 Third Hospital Avenue #03-03 Bowyer Block C Singapore 168753
Tel: 65–6225 0488 Fax: 65–6557 2138www.singhealth.com.sg
SingHealth Group Procurement Office re
www.uktradeinvest.gov.uk Page 16 of 20
Healthcare – Singapore
7, Hospital Drive #02-09 Block B Singapore 169611
Tel: 65-6225 0488 Fax: 65-6327 8768www.singhealth.com.sghttp://gpo.nhg.singhealth.com.sg
National Healthcare Group Pte Ltd (Western Cluster)6 Commonwealth Lane Level 6, GMTI Building Singapore 149547
Tel: 65–6496 6600 Fax: 65–6496 6870www.nhg.com.sg
National Healthcare GroupGroup Purchasing Office (GPO)6 Commonwealth LaneLevel 6 GMTI BuildingSingapore 149547
Tel: 65–6496 6600 Fax: 65–6496 6870www.nhg.com.sg/gpo/index.htm
Economic Development Board (EDB)250 North Bridge Road #28-00Raffles City TowerSingapore 179101Tel: (65) 6832 6832 Fax: (65) 6832 6565www.edb.gov.sg
Agency for Science, Technology and Research (A*STAR)20 Biopolis Way #07-01 CentrosSingapore 138668
Tel: 65–6826 6111 Fax: 65-6777 1711 E-mail: [email protected]
Yong Loo Lin School of Medicine, NUSLevel 2 Clinical Research Centre (MD11)10 Medical DriveSingapore 117597
Tel: 65-6516 3297 Fax: 65-6778 5743www.med.nus.edu.sg
Health Sciences Authority (HSA)11 Outram Road
www.uktradeinvest.gov.uk Page 17 of 20
Healthcare – Singapore
Singapore 169078
Tel: 65-6213 0838 Fax: 65–6213 0749www.hsa.gov.sg
Health Promotion Board (HPB)3 Second Hospital Avenue #06-00Singapore 168937
Tel 65–6435 3500 Fax: 65–6438 3848E-mail: [email protected]
Singapore Medical Council16 College Road#01-01 College of Medicine BuildingSingapore 169854
Tel: 65–6372 3061/2/3/4/5 Fax: 65–6221 0558E-mail: [email protected]
Singapore Dental Council 16 College Road#01-01 College of Medicine BuildingSingapore 169854
Tel: 65–6372 3076 Fax: 65–6221 1275E-mail: [email protected] www.sdc.gov.sg
Singapore Nursing Board 16 College Road#01-01 College of Medicine BuildingSingapore 169854 Tel: 65–6372 3082 / 6372 3083 Fax: 65–6221 1160E-mail: [email protected]
Specialists Accreditation Board 16 College Road#01-01 College of Medicine BuildingSingapore 169854
www.uktradeinvest.gov.uk Page 18 of 20
Healthcare – Singapore
Tel: 65-6325 9160 Fax: 65-6325 9211 E-mail: [email protected]/SAB/SAB_Home.html
The Academy of Medicine, Singapore142, Neil RoadRunme Shaw BuildingSingapore 088871
Tel: 65-6223 8968 Fax: 65-6225 5155 E-mail: [email protected] www.academyofmedicine.edu.sg
Singapore Medical Association 2 College RoadLevel 2, Alumni Medical CentreSingapore 169850 Tel: 65–6223 1264 Fax: 65–6224 7827E-mail: [email protected]
Singapore College of Family Physicians 16 College Road #01-02College of Medicine BuildingSingapore 169854 Tel: 65-6223 0606 Fax: 65-6222 0204E-mail: [email protected]
Singapore Nurses' Association SNA House77, Maude RoadSingapore 208353 Tel: 65 - 6392 0770 Fax: 65 - 6392 7877E-mail: [email protected] Website : www.sna.org.sg
Singapore Tourism Board (Healthcare Services)Tourism Court1 Orchard Spring LaneSingapore 247729
Tel: 65-6736 6622 Fax: 65-6736 9423E-mail: [email protected]
www.uktradeinvest.gov.uk Page 19 of 20
Healthcare – Singapore
www.stb.gov.sg
Housing & Development BoardHDB Hub480 Lorong 6 Toa PayohSingapore 310480
Tel: 65-6490 1111 Fax: 65-6490 1033E-mail: [email protected]://www.hdb.gov.sg
www.uktradeinvest.gov.uk Page 20 of 20
![lostshtetl.comlostshtetl.com/.../uploads/2015/10/Seduva_kapines_EN.docx · Web viewSector A 5 פנ... בת ר צבי נפטרה ביום כח אדר שנת [תרם] תנצבה Here](https://img.pdfslide.us/doc/110x75/5e4dcb49abebc15056115ff7/web-view-sector-a-5-.jpg)
